Is Ocugen a Buy After Doubling Last Week?
If you want to find stocks that can produce huge gains in short time spans, the biopharmaceutical space has lots of what you're looking for. Shares of drugmaker called Ocugen (NASDAQ: OCGN) more than tripled last Monday, and investors want to know if it's too late to buy some for their own portfolios.
Shares of this biotech stock had been flying way under the radar before the company and its international collaboration partner began making progress with a potential new coronavirus vaccine. Now that it's one of the most popular stocks in the biopharma space, can it keep producing big gains?
Image source: Getty Images.
Source Fool.com
